NAKA

Nakamoto is no longer an operating company in any conventional sense. The 10-K is explicit: management is abandoning the legacy Kindly MD healthcare business — the only thing producing revenue — to 'focus on the acquisition and holding of Bitcoin as our primary treasury reserve asset.' Future results 'will now be primarily driven by the market price of Bitcoin, which is notoriously volatile.' So the $1.82M of FY2025 revenue (down 33% YoY, and down from $3.77M in FY2023) is a runoff number, not a base to grow from. Buyers at a $2.9B market cap are paying 1591x sales for a revenue stream the company intends to exit.

The FY2025 income statement is dominated by mark-to-market noise, not operations: a $197M operating loss built almost entirely from a $166.1M loss on the change in fair value of digital assets (BTC fell from $114,078 at Sep 30 to $87,519 at Dec 31) plus a $9.9M loss on investments, and a $52.2M bottom-line loss further swung by a $226.4M call-option fair-value gain netted against a $59.8M loss on the Nakamoto acquisition and $14.7M of debt-restructuring costs. Earnings are now a derivative of Bitcoin's quarterly close — unforecastable and unrelated to any durable enterprise. Operating cash flow was -$23.5M against just $22.6M of cash, and interest expense ballooned to $7.1M, so the balance sheet is thin relative to the burn despite $514M of (acquisition-inflated) equity.